Skip to main content

Advertisement

Table 2 Comparison of primary and secondary outcome measures in TASMC groups

From: Clinical benefits of FilmArray meningitis-encephalitis PCR assay in partially-treated bacterial meningitis in Israel

Variable Cases (n = 8) Control (n = 23) p-value
Initial antimicrobial regimen duration (days) 3.5 ± 4.7 4.3 ± 3.4 0.52
Final antimicrobial regimen duration (days) 8.6 ± 3.7 12.8 ± 4.6 0.03
Total antimicrobial treatment duration (days) 9.5 ± 3.7 15.2 ± 3.7 0.007
Narrow spectrum antibiotic treatment duration (% from total duration) 78 ± 11 40 ± 9 0.03
Duration of guideline-adherent antimicrobial regimen (% from total duration) 93 ± 3 45 ± 9 0.006
Administration of steroids 3 (38) 9 (39) 0.94
Antimicrobial chemoprophylaxis for close contacts 4 (50) 1 (4) 0.01
In-hospital mortality 2 (25) 1 (4) 0.31
ICU admission duration (%) 21 ± 35 14 ± 26 0.5566
ICU admission 4 (50) 9 (39) 0.9
Length of stay (days) 10 ± 4 17 ± 9 0.065
Poor functional outcome (mRS ≥ 4) 2 (25) 3 (13) 0.82
  1. Bold values are significant